Idiopathic Intracranial Hypertension: Diagnosis & Clinical Features

Idiopathic intracranial hypertension (IIH) is a condition of elevated intracranial pressure (ICP) of unknown etiology, occurring most commonly in young women with obesity. Previously termed pseudotumor cerebri or benign intracranial hypertension, IIH is increasingly recognized as a systemic metabolic disorder associated with significant morbidity, including progressive and potentially permanent vision loss. The incidence has risen in parallel with the obesity epidemic, making it a condition of growing importance in neurologic practice. Accurate diagnosis requires careful application of the modified Dandy criteria, thorough ophthalmologic evaluation, and systematic exclusion of secondary causes.

Bottom Line

  • Epidemiology: Incidence ~1.97/100,000 in women; rising in parallel with obesity rates; F:M ratio 8:1 in reproductive years
  • Hallmark: Papilledema is the hallmark sign — present in the vast majority; a small subset has IIH without papilledema
  • Visual symptoms: Transient visual obscurations (TWO), visual field defects (enlarged blind spot, nasal step), and sixth nerve palsy
  • Headache: Present in 78–95% but lacks distinctive features; phenotype most commonly resembles migraine
  • Diagnostic criteria (Friedman 2013): Papilledema + normal neurologic examination (except VI nerve) + normal neuroimaging + elevated CSF opening pressure (≥25 cm H2O / ≥250 mm CSF) + normal CSF composition
  • MRI features: Empty or partially empty sella, flattening of the posterior globe, distension of perioptic subarachnoid space, transverse sinus stenosis
  • Diagnostic pitfalls: Overdiagnosis occurs in ~40% of referrals; ophthalmoscopy must be performed; isolated MRI features are not diagnostic

Epidemiology

Parameter Data
Overall incidence 0.9–1.97 per 100,000 per year
Women of reproductive age 3.5–19 per 100,000 per year (rising with increasing BMI)
Men ~0.5 per 100,000 per year
Children 0.5–0.7 per 100,000; prepubertal cases show equal sex distribution
Sex ratio (adults) F:M approximately 8:1
BMI association Risk increases exponentially above BMI 30 kg/m²
Racial disparities Higher prevalence in Black women in the United States
Trend Incidence increasing, mirroring rising obesity rates globally

Risk Factors and Associations

  • Obesity: The primary modifiable risk factor; IIH is increasingly viewed as a systemic metabolic disorder
  • Weight gain: Even 5–15% weight gain carries risk for both developing and recurring IIH
  • Obstructive sleep apnea: Potential contributor to worse visual outcomes; consider screening in patients who do not fit the typical demographic
  • Polycystic ovarian syndrome: 1.5-fold increased risk; phenotypically similar hyperandrogenic disorder
  • Cardiovascular risk: IIH associated with increased risk of cardiovascular events in women
  • Mental health: Depression, anxiety frequently coexist and may worsen outcomes; suicide risk is more than 6 times higher than in the general population

Diagnostic Criteria (Friedman 2013, Pseudotumor Cerebri Syndrome)

Diagnostic Criteria for IIH

  1. Signs and symptoms of elevated ICP: Papilledema, headache, pulsatile tinnitus, transient visual obscurations, diplopia from sixth nerve palsy
  2. Normal neurologic examination except for papilledema, sixth nerve palsy, or visual field defect
  3. Neuroimaging: No evidence of hydrocephalus, mass lesion, structural cause, or abnormal meningeal enhancement on MRI with contrast and MR or CT venography
  4. Elevated CSF opening pressure: ≥25 cm H2O (≥250 mm CSF) in adults, ≥28 cm H2O (≥280 mm CSF) in children — ≥25 cm if the child is unsedated and non-obese (measured in the lateral decubitus position, legs extended, patient relaxed)
  5. Normal CSF composition: Normal cell count, glucose, and protein

Clinical Features

Papilledema

Papilledema — bilateral optic disc swelling caused by elevated ICP transmitted along the optic nerve sheath — is the hallmark sign of IIH and the primary determinant of treatment urgency.

Frisén Grade Description Clinical Significance
Grade 0 Normal optic disc No papilledema
Grade 1 C-shaped halo of disc edema; obscuration of nasal disc border Mild; may be subtle and difficult to distinguish from pseudopapilledema
Grade 2 Circumferential halo of disc edema; obscuration of all disc margins Moderate; visual function usually preserved
Grade 3 Obscuration of one or more major retinal vessels leaving the disc Moderate to severe; monitor closely for visual deterioration
Grade 4 Obscuration of all major vessels on the disc; possible retinal folds Severe; visual function at risk; consider escalation of treatment
Grade 5 Total obscuration of disc; dome-shaped protrusion; retinal vessel obscuration extends beyond disc margin Very severe; vision-threatening; urgent intervention required

Critical Points About Papilledema

  • Papilledema can be asymmetric — unilateral or significantly different between eyes
  • Some patients are asymptomatic with papilledema discovered incidentally on routine eye examination
  • Headache frequency and severity do not correlate with papilledema severity — patients with minimal headache can have severe papilledema
  • Rapidly declining visual acuity suggests severe optic nerve ischemia and requires urgent evaluation
  • Acquired dyschromatopsia (abnormal color vision) in the setting of papilledema is a serious sign indicating threatening optic neuropathy

Visual Symptoms

Symptom Description Frequency
Transient visual obscurations Brief (seconds) episodes of monocular or binocular visual dimming or graying; often triggered by positional change ~68%
Visual field loss Enlargement of blind spot (earliest), nasal step, arcuate defects, generalized constriction (late) Progressive; may be asymptomatic until advanced
Diplopia Horizontal binocular diplopia from unilateral or bilateral sixth (abducens) nerve palsy; false localizing sign ~20–30%
Blurred vision May reflect papilledema-related hypermetropic shift or incipient visual field loss Common
Photopsia Flashes of light; less common than in retinal disease Occasional

Headache

  • Present in 78–95% of IIH patients
  • The headache phenotype most commonly resembles migraine (52% in the IIHTT), followed by tension-type (22%) and probable migraine (16%)
  • Headache lacks distinctive features that reliably distinguish it from primary headache disorders
  • IIH patients are 6 times more likely to develop migraine than the general population
  • A potential differentiator: headaches associated with elevated ICP are often worse on awakening and may worsen with Valsalva
  • Headache severity does not correlate with opening pressure, papilledema grade, or visual function

Other Symptoms

  • Pulsatile tinnitus: Rhythmic whooshing sound synchronous with the heartbeat; present in ~52–60%; may be the presenting complaint
  • Neuro-otologic symptoms: Hearing loss, dizziness, aural fullness
  • Cognitive symptoms: Difficulty concentrating, brain fog, reduced processing speed; reversible with treatment
  • Neck and back pain: Radicular symptoms can occur from nerve root sleeve distension

Diagnostic Investigations

Ophthalmologic Assessment

Essential Visual Monitoring

  • Visual acuity: High-contrast best-corrected visual acuity at 6 meters; recheck with pinhole; declining acuity is a serious sign
  • Color vision: Pseudoisochromatic plates; abnormal color vision indicates optic nerve dysfunction
  • Pupil examination: Relative afferent pupillary defect indicates asymmetric optic nerve damage
  • Visual field testing: Automated perimetry (Humphrey 24-2) at every visit; most sensitive measure of visual function in papilledema
  • Fundoscopy: Dilated examination to grade papilledema (Frisén scale); fundus photography for documentation
  • OCT (optical coherence tomography): Peripapillary retinal nerve fiber layer thickness — the most sensitive objective measure for monitoring papilledema change over time

Neuroimaging

MRI Finding Description Sensitivity/Specificity
Empty or partially empty sella Flattened pituitary gland from CSF pressure on the diaphragma sellae Moderate sensitivity; not specific
Flattening of the posterior globe Inward bowing of the posterior sclera from elevated optic nerve sheath pressure High specificity
Perioptic subarachnoid space distension CSF distension of the optic nerve sheath; tortuous optic nerve Moderate; more common with higher ICP
Transverse sinus stenosis Bilateral narrowing at the transverse-sigmoid junction on MR or CT venography Present in >90% of IIH patients; also common in the general population
Optic nerve head protrusion Protrusion of the optic disc into the vitreous Correlates with papilledema grade

Neuroimaging Pitfalls

  • A combination of ≥3 MRI features is ~100% specific and ~64% sensitive for identifying papilledema in IIH patients
  • MRI features alone, without clinical confirmation of papilledema or sixth nerve palsy, are not diagnostic of IIH
  • Incidental MRI findings associated with IIH are common in the general population (especially transverse sinus stenosis and empty sella) and should not trigger a diagnosis without papilledema
  • Treatment trials for IIH did not include patients with IIH without papilledema

Lumbar Puncture

  • Position: Lateral decubitus, legs extended, patient relaxed, head in neutral position
  • Elevated opening pressure: >25 cm H2O for adults; >28 cm H2O for children
  • Sedation caution: In children, sedation may cause hypercapnia and falsely elevate CSF pressure
  • Normal CSF: Cell count, glucose, and protein must be normal for IIH diagnosis
  • Note: Opening pressure does not correlate with disease activity, visual loss, or need for emergency management — treatment decisions should be guided by visual function

MR/CT Venography

  • Required to exclude cerebral venous sinus thrombosis as a secondary cause of elevated ICP
  • Bilateral transverse sinus stenosis is common in IIH but is usually extrinsic compression from elevated ICP (not thrombotic)
  • Venous sinus stenosis may play a pathogenic role in some patients and is a target for stenting in refractory cases

IIH Without Papilledema

A diagnosis of IIH can be suggested in the absence of papilledema or sixth nerve palsy if:

  • All other modified Dandy criteria are met
  • At least 3 typical MRI features are present (empty sella, posterior globe flattening, perioptic subarachnoid space distension, transverse venous sinus stenosis)
  • Elevated opening pressure is documented (≥25 cm H2O)

IIH Without Papilledema: Key Points

  • Patients typically have chronic headaches with elevated ICP but no visual loss
  • It is unclear whether this represents a distinct entity or early IIH before papilledema develops
  • These patients should be monitored longitudinally for possible delayed papilledema development
  • Treatment trials (IIHTT) did not include this population
  • Overdiagnosis is a risk — isolated MRI features plus headache do not establish the diagnosis

Diagnostic Errors

A retrospective study of 165 patients referred to a neuro-ophthalmology clinic with a diagnosis of IIH found that overdiagnosis had occurred in 39.5%:

  • Underuse of diagnostic tests: Failure to perform ophthalmoscopy or OCT; not performing visual fields
  • Overuse of diagnostic tests: Relying on isolated MRI findings (e.g., empty sella or transverse sinus stenosis) without confirming papilledema
  • Anchoring bias: Assuming obese women with headache have IIH without proper diagnostic workup
  • Consequences: Unnecessary medications (acetazolamide side effects), invasive procedures, and missed alternative diagnoses

Differential Diagnosis

Condition Key Distinguishing Features
Cerebral venous sinus thrombosis Filling defect on venography; may have focal neurologic signs; fever, hypercoagulable state
Intracranial mass lesion Focal neurologic signs; mass on MRI; may have papilledema
Meningitis (infectious or neoplastic) Abnormal CSF composition (pleocytosis, elevated protein, low glucose); meningeal enhancement on MRI
Medication-induced intracranial hypertension Tetracyclines (minocycline, doxycycline), vitamin A/retinoids, growth hormone; resolves with discontinuation
MOGAD with bilateral optic disc edema Can mimic fulminant IIH; up to 21% have elevated opening pressure; MRI orbits with contrast recommended
Pseudopapilledema Optic disc drusen; elevated disc without true swelling; OCT and autofluorescence can differentiate
Obstructive hydrocephalus Ventricular enlargement on imaging; different mechanism of elevated ICP

References

  1. Antonio LB. Clinical features and diagnosis of idiopathic intracranial hypertension. Continuum (Minneap Minn). 2025;31(3):709-727.
  2. Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81(13):1159-1165.
  3. NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss. JAMA. 2014;311(16):1641-1651.
  4. Mollan SP, Aguiar M, Evison F, et al. The expanding burden of idiopathic intracranial hypertension. Eye (Lond). 2019;33(3):478-485.
  5. Fisayo A, Bruce BB, Newman NJ, Biousse V. Overdiagnosis of idiopathic intracranial hypertension. Neurology. 2016;86(4):341-350.